BioGend Therapeutics Co Ltd

ROCO:6733 (Taiwan)   Ordinary Shares
NT$ 37.00 (+2.49%) Nov 29
At Loss
P/B:
5.23
Market Cap:
NT$ 4.60B ($ 141.66M)
Enterprise V:
NT$ 3.97B ($ 122.45M)
Volume:
105.00K
Avg Vol (2M):
170.43K
Trade In:
Volume:
105.00K
At Loss
Avg Vol (2M):
170.43K

BioGend Therapeutics Co Ltd Operating Data

BioGend Therapeutics Co Ltd Competitors' Latest Operating Data

Operating data not available.

BioGend Therapeutics Co Ltd (ROCO:6733) Operating Data Charts